Amgen Inc (AMGN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$348.98
Buy
$352.60
$2.85 (+0.82%)
Prices updated at 01 Apr 2026, 00:53 EDT
| Prices minimum 15 mins delay
Prices in USD
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Robert A. Bradway
CEO
Mr. Robert A. Bradway
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
31,500
Head office
One Amgen Center Drive
Thousand Oaks
United States
91320-1799
Key personnel
Owner name | Salary |
|---|---|
Ms. Amy E. Miles Independent Director | 0.14m |
Mr. Charles M. Holley, Jr Independent Director | - |
Ms. Ellen J. Kullman Independent Director | 0.15m |
Mr. Robert A. Eckert Lead Independent Director | 0.21m |
Mr. Robert A. Bradway Chairman of the Board, President and Chief Executive Officer | 1.87m |
Professor Dr. Tyler E. Jacks, PhD Independent Director | 0.14m |
Mr. Jonathan P. Graham Executive Vice President, General Counsel and Secretary | - |
Mr. Greg C. Garland Independent Director | 0.16m |
Mr. Murdo Gordon Executive Vice President, Global Commercial Operations | 1.20m |
Dr. James E. Bradner, M.D. Executive Vice President, Research and Development | 1.21m |
Mr. Esteban Santos Executive Vice President, Operations | - |
Dr. Wanda M. Austin Independent Director | 0.14m |
Dr. Brian J. Druker, M.D. Independent Director | 0.14m |
Dr. David M. Reese, M.D. Executive Vice President and Chief Technology Officer | 1.27m |
Mr. Peter H. Griffith Executive Vice President and Chief Financial Officer | 1.13m |
Ms. Nancy A. Grygiel Senior Vice President and Chief Compliance Officer | - |
Dr. S. Omar Ishrak Independent Director | - |
Ms. Rachna Khosla Senior Vice President, Business Development | - |
Mr. Derek Miller Senior Vice President, Human Resources | - |
Mr. Michael V. Drake Independent Director | - |
Mr. Matthew C. Busch Vice President, Finance and Chief Accounting Officer | - |
Ms. Mary E. Klotman Independent Director | 0.08m |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 54,838,826 |
| BlackRock Inc | 46,034,432 |
| Capital Research and Management Company | 44,809,474 |
| State Street Corp | 29,304,093 |
| Capital Group | 26,930,578 |
Director dealings
Date | Action |
|---|---|
| 20 Nov 2025 | - |
| 20 Nov 2025 | - |
| 20 Nov 2025 | - |
| 20 Nov 2025 | - |
| 20 Nov 2025 | - |
| 20 Nov 2025 | - |
| 12 Nov 2025 | - |
| 12 Nov 2025 | - |
| 12 Nov 2025 | - |
| 11 Nov 2025 | - |
| 07 Nov 2025 | - |
| 07 Nov 2025 | - |
| 05 Nov 2025 | - |
| 05 Nov 2025 | - |
| 20 Aug 2025 | - |
| 08 Aug 2025 | - |
| 08 Aug 2025 | - |
| 05 Jun 2025 | - |
| 23 May 2025 | - |
| 23 May 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
